More on Surescripts Report
...
Top Story
Featured Stories
More on Surescripts Report
A recent PatientEngagementHIT report highlights a survey by Surescripts that found high drug prices caused a little more… Read more
Survey: More than Half of Patients Avoid Taking Medicine Due to Cost
A recent survey conducted by Surescripts, in partnership with Engine Group, suggests a little more than half of U.S.… Read more
CMS Testing Waters with Risk-Sharing Deals with ACO Program
The Centers for Medicare and Medicaid Services (CMS) is testing risk-sharing agreements in Medicare's Direct Contracting… Read more
Latest Stories
More on Surescripts Report
A recent PatientEngagementHIT report highlights a survey by Surescripts that found high drug prices caused a little more than half of U.S. patients to avoid taking their medicines. The survey included input from 1,001 patients. "A patient's decision about whether or not to take a prescribed […]
Survey: More than Half of Patients Avoid Taking Medicine Due to Cost
A recent survey conducted by Surescripts, in partnership with Engine Group, suggests a little more than half of U.S. patients avoid taking medication due to high prices. The online survey included responses from 1,001 patients in the U.S. "This survey demonstrates that today's patients are […]
CMS Testing Waters with Risk-Sharing Deals with ACO Program
The Centers for Medicare and Medicaid Services (CMS) is testing risk-sharing agreements in Medicare's Direct Contracting program, according to a Managed Care report. According to the report, the agency is accepting applications from potential "direct contracting entities" for the program until […]
Blog Post: Making the Most of Our Health Care Dollars
A recent blog post on Going Below the Surface highlights a panel discussion during AcademyHealth National Health Policy Conference that focused on more effective health care spending. The panel, which was moderated by National Pharmaceutical Council CSO Robert Dubois, featured: Stacie […]
Impact of Drug Pricing Controls on Innovation
The pharmaceutical industry, citing concerns over innovation, has consistently pushed back against the U.S. government's efforts to tame drug prices. But what impact would pricing controls actually have on innovation? According to a MedCity News article, the issue is a complicated one with a […]
3M Announces Webinar Series for Health Plans
3M this week announced a new webinar series developed specifically for health care plans. The first webinar in the series, "Incenting the shift to value-based care," is set to kick off 2 p.m. EST March 17. "The 3M payer webinar series offers in-depth sessions with 3M experts and clients about […]
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic Platform, hēRo3
Via Press Release Policy Analysis Inc. (PAI), a Boston-based health-economics consultancy, on Wednesday, Feb. 19, announced that it had signed a multi-year deal with the Institute for Clinical and Economic Review (ICER) that will allow the drug-pricing watchdog to expand its use of PAI's new […]
Article Reflects on NICE’s Achievements, Economic Evaluation Methods
University of York's Mark Sculpher and Stephen Palmer in a recent article published in PharmacoEconomics discuss the National Institute for Health and Care Excellence's track record of achievements and the evolution of its economic evaluation methods. Sculpher and Palmer in their review go back […]
Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives
Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug pricing initiatives circulating in Washington. To listen to the 15-minute podcast, click here. […]
Express Scripts Releases Annual Drug Trend Report
Express Scripts in its annual Drug Trend Report suggests drugs targeting inflammatory conditions were responsible for almost half of the drug spending in commercial plans last year, Fierce Healthcare reports. In its report, the pharmacy benefit manager looks at cost and spending data for 33.6 […]
